Table 3.
Overall survival (OS) | |||
---|---|---|---|
n a | Events | p valueb | |
Parameter: | |||
RBBP8 methylationc | |||
RBBP8 Mlow | 262 | 103 | 0.039 |
RBBP8 Mhigh | 85 | 24 | |
Gender | |||
Male | 253 | 91 | 0.920 |
Female | 94 | 36 | |
Histological tumor graded | |||
Low grade | 15 | 0 | 0.066 |
High grade | 329 | 127 | |
Tumor stage | |||
pT1-pT2 | 105 | 23 | ≤ 0.001 |
pT3-pT4 | 214 | 94 | |
pN status | |||
Negative | 207 | 53 | ≤ 0.001 |
Nositive | 111 | 63 | |
pM status | |||
Negative | 168 | 52 | 0.004 |
Positive | 7 | 5 |
Significant p values are in italics
aOnly patients with primary bladder cancer without any neoadjuvant therapy were included
bLog-rank test at the two-sided significance level of 0.05